Home/Renalytix/Michael J. Donovan
MJ

Michael J. Donovan

Chief Medical Officer

Renalytix

Renalytix Pipeline

DrugIndicationPhase
KidneyIntelX.dkdProgressive decline in kidney function in adults with Type 2 Diabetes and CKD Stages 1-3bCommercial
KidneyIntelX in Heart FailureRisk of worsening kidney function in patients with heart failureDevelopment
KidneyIntelX for CKD EtiologyDisease sub-typing and causation in broad CKD populationResearch